Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6064496 | 0.89 | ALDH1A1 (0.50) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL6064499 | 0.89 | ALDH1A1 (0.50) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL27711459 | 0.88 | ALDH1A1 (0.49) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL16915235 | 0.85 | SLC1A3 (0.45) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL16915234 | 0.85 | SLC1A3 (0.45) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL30600448 | 0.84 | ALDH1A1 (0.51) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL29462738 | 0.84 | ALDH1A1 (0.47) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL4647195 | 0.83 | ALDH1A1 (0.44) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL28006785 | 0.82 | ALDH1A1 (0.46) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 | |
| SCHEMBL27780857 | 0.82 | LTA4H (0.44) | ALDH1A1SLC15A1KMT2ASLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541018-B2 | Treatment process using somatostatin analogues | UNIVERSITY OF BERN (CH) | 2009-06-02 | — | — | US | disclosed |
| US-20070154392-A1 | TREATMENT PROCESS USING SOMATOSTATIN ANALOGUES | UNIVERSITY HOSPITAL BASEL (CH) | 2007-07-05 | — | — | US | disclosed |
| US-7192570-B2 | Compositions of somatostatin analogues | UNIVERSITY OF BERN (CH) | 2007-03-20 | — | — | US | disclosed |
| EP-1419178-B1 | SOMATOSTATIN ANALOGUES AND THEIR USE SOMATOSTATIN ANALOGUES BINDING TO ALL SOMATOSTATIN RECEPTOR AND THEIR USE | UNIV BERN (CH) | 2006-05-31 | — | — | EP | disclosed |
| US-20040242842-A1 | Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use | UNIVERSITY OF BERN (CH) | 2004-12-02 | — | — | US | disclosed |
| EP-1419178-A1 | SOMATOSTATIN ANALOGUES AND THEIR USE SOMATOSTATIN ANALOGUES BINDING TO ALL SOMATOSTATIN RECEPTOR AND THEIR USE | University of Bern (CH) | 2004-05-19 | — | — | EP | disclosed |
| WO-2003014158-A1 | SOMATOSTATIN ANALOGUES AND THEIR USE SOMATOSTATIN ANALOGUES BINDING TO ALL SOMATOSTATIN RECEPTOR AND THEIR USE | UNIVERSITY OF BERN (CH) | 2003-02-20 | — | — | WO | disclosed |
| EP-1283216-A1 | Somatostatin analogues binding to all somatostatin receptor subtypes and their use | Mallinckrodt Inc. (US) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154392-A1 | TREATMENT PROCESS USING SOMATOSTATIN ANALOGUES | NPR1, NPR3, SSTR3 | ALDH1A1 4762/4885SLC15A1 458/4885KMT2A 1395/4885 |
| US-20040242842-A1 | Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use | SSTR5, NPY5R, GLP1R | ALDH1A1 3997/4885SLC15A1 703/4885KMT2A 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.